KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Revenue (2016 - 2025)

Historic Revenue for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to $38.4 million.

  • Pacific Biosciences Of California's Revenue fell 381.81% to $38.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $154.6 million, marking a year-over-year decrease of 1072.09%. This contributed to the annual value of $154.0 million for FY2024, which is 2319.31% down from last year.
  • Pacific Biosciences Of California's Revenue amounted to $38.4 million in Q3 2025, which was down 381.81% from $39.8 million recorded in Q2 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Revenue peaked at $58.4 million during Q4 2023, and registered a low of $27.4 million during Q4 2022.
  • Moreover, its 5-year median value for Revenue was $37.2 million (2025), whereas its average is $38.4 million.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 11334.77% in 2023, then plummeted by 3278.61% in 2024.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Revenue stood at $36.0 million in 2021, then decreased by 24.06% to $27.4 million in 2022, then soared by 113.35% to $58.4 million in 2023, then crashed by 32.79% to $39.2 million in 2024, then dropped by 2.0% to $38.4 million in 2025.
  • Its last three reported values are $38.4 million in Q3 2025, $39.8 million for Q2 2025, and $37.2 million during Q1 2025.